This invention discloses a process to produce high amounts of extracellular tyrosinase from the fungus Gliocephalotrichum MTCC 5489 by growing the fungus in a suitable culture medium under conditions of appropriate pH, temperature and oxygen conditions. The fungus is capable of producing tyrosinase enzyme having bot...
This invention relates to a process to produce antiviral polysaccharides derived from extracellular culture filtrate of marine Iabyrinthulomycetes. The antiviral polysaccharide is particularly effective against the Herpes Simplex Virus (HSV) and is derived from marine, heterotrophic protists belonging to thraustochy...
The present invention relates to the production of melanin for various pharmaceutical, cosmaceutical and industrial applications. It particularly relates to a process to produce water soluble melanin for the puipose. This invention further relates to the production of water soluble melanin from a strain of the fungu...
The present invention relates to a process to biotransform biologically active compounds of medicinally useful plants using the enzyme laccase. It also presents a process to biotransform biologically active herbal preparations of medicinally useful plants using the enzyme laccase. These processes enhance the bioacti...
[0047] This invention discloses a process of production of antiviral polysaccharides derived from extracellular culture filtrate of thraustaochytrids, belonging to the marine protistan group of Labyrinthulomycetes. The antiviral polysaccharide shows a broad-spectrum antiviral activity, being active against viruses s...
Charges
10 Lak
26 March 2009
Department Of Biotechnology
10 Lak
26 March 2009
Department Of Biotechnology
0
26 March 2009
Department Of Biotechnology
0
26 March 2009
Department Of Biotechnology
0
Documents
Form ADT-1-05122020_signed
Copy of resolution passed by the company-05122020
Copy of written consent given by auditor-05122020
Directors report as per section 134(3)-05122020
List of share holders, debenture holders;-05122020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-05122020
Form MGT-7-05122020_signed
Form AOC-4-05122020_signed
Form AOC-4-22112019_signed
Form MGT-7-22112019_signed
List of share holders, debenture holders;-21112019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-21112019
Directors report as per section 134(3)-21112019
List of share holders, debenture holders;-22122018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-22122018
Directors report as per section 134(3)-22122018
Form MGT-7-22122018_signed
Form AOC-4-22122018_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-13102017
List of share holders, debenture holders;-13102017
Directors report as per section 134(3)-13102017
Form AOC-4-13102017_signed
Form MGT-7-13102017_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-26102016
List of share holders, debenture holders;-26102016